Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
about
Imaging and drug delivery using theranostic nanoparticlesTowards nanomedicines for neuroAIDS.Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.Current advances in polymer-based nanotheranostics for cancer treatment and diagnosisDevelopment of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesPolymeric micelles as mighty nanocarriers for cancer gene therapy: a review.Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.Nanoparticles as delivery carriers for anticancer prodrugs.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Polymeric materials for theranostic applications.Multifunctional nanoparticles: recent progress in cancer therapeutics.Topical drug delivery systems: a patent review.Nano-ART and NeuroAIDS.Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.Self-aligning amelogenin nanoribbons in oil-water system.Polypeptide self-assemblies: nanostructures and bioapplications.Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.Stimuli-responsive liposomes for drug delivery.Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release.Nanomicelles: an emerging platform for drug delivery to the eye.Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis.Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.Spatiotemporal Control of Doxorubicin Delivery from "Stealth-Like" Prodrug Micelles.Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma.Insight into curcumin nanomicelle-induced derangements in male reproduction potential: An experimental study.Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone.Structured substrates and delivery vehicles: trending now in biomedicine.Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.Nanocapsules templated on liquid cores stabilized by graft amphiphilic polyelectrolytes.Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.Ocular Drug Delivery.A Comparative Study of Cellular Uptake and Subcellular Localization of Doxorubicin Loaded in Self-Assemblies of Amphiphilic Copolymers with Pendant Dendron by MDA-MB-231 Human Breast Cancer Cells.Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.Molecular Features Influencing the Release of Peptides from Amphiphilic Polymeric Reverse Micelles.Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
P2860
Q30449480-4E89CE04-4446-4C0E-8C89-EC1DBF667AF4Q34495140-D2DAAB9E-6446-49CB-AB70-817C5BA91586Q34512297-05B9C021-CB9C-4E88-A5CB-73EF5FC70980Q34783018-E3C54AF0-61DD-481E-9C8D-6F708B756608Q34797004-B03FB091-BCD7-4FB0-B1A0-74244DF989BBQ36313520-3B530592-2A07-4070-8364-8B278360896FQ37638763-B4596397-3A8F-4517-88B1-BA7B894E9F5FQ38002956-16EEBF29-064F-4C9C-9627-7FD03BE4CDA3Q38100561-155D4345-B1AD-4F80-A136-0A5A4428AE73Q38114360-CEAD26D8-AD1C-40D1-B3B6-8F09F7C8CBB9Q38559193-2ED1380B-FC8B-412C-BFE5-0A335789CFFCQ38664367-C7EDAB0E-9C31-4F55-94DE-79A5D50D2C2EQ38823456-A2FD6541-C1BE-4552-807C-FC1A0D691EE6Q38837166-553078F8-C78A-49B1-96A5-041E714F7749Q38880491-B093A63A-5872-48F8-A2E9-15E0D79FEFEFQ38976855-BB9DCDAB-41DB-4ABF-B71C-B5DD3905B0DDQ39087808-17DE494B-55AB-4F8D-A182-05FB4AF3FA2EQ39136162-925DA800-FBFD-465A-8BD9-EE83204694FEQ39517242-FE328FD4-9FA2-4C7C-8784-70E7FAC76CC7Q39867514-136BF9E0-B05B-4BAA-AB24-A8694DEC5128Q40980060-3553203B-9FC8-4F0C-8C60-147D9FFC24F8Q41283476-CD609DEB-A96B-45E8-9596-1AF4F39E5FC4Q41890311-1B402C4E-FA24-4EF3-89C0-E2B3D77A0D11Q42283198-B13B1D61-C651-4C0E-B2B5-A6DA87336F6DQ42339249-38A3D280-525A-46D3-9B75-ADF87CCDC2FAQ42378276-46456B5B-C65D-4545-A45D-3125A22B612EQ43202469-AC83E574-AA42-4A37-977C-246B199EB288Q48132164-D8627DC6-654F-4998-B426-B6FA9076AF7FQ48150397-413F442C-BA09-46E4-81CE-2ED2B9FF7331Q48330948-D6C393CA-D05B-4CD2-8611-4A49E933D3E6Q49874284-74F63936-929D-4EC6-868E-6471660F2706Q50501989-0CE0B5D7-D773-4812-B134-A84F11EDB0C9Q50936528-9E627969-5BE5-429D-ABDF-9423B7435587Q51002322-E3E3694F-7E4F-4B55-9994-92A08236A939Q51002793-65EAB138-59C3-4788-A169-0C0C7C49DBA3Q51122641-EFE6876A-7A5F-47F1-8340-42FF52C882C8Q51504830-D2C5F76E-376C-4FB7-BE29-BA1F4C12B082Q52679059-F293AA91-6549-4396-B9C2-DE099F18A3D4Q52689931-3EE06CF5-A140-41B3-A99F-82101A679E19Q53073687-EBE12064-16EF-4A98-8257-3A046C52E73C
P2860
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanomicellar formulations for ...... ies and underlying principles.
@en
Nanomicellar formulations for ...... ies and underlying principles.
@nl
type
label
Nanomicellar formulations for ...... ies and underlying principles.
@en
Nanomicellar formulations for ...... ies and underlying principles.
@nl
prefLabel
Nanomicellar formulations for ...... ies and underlying principles.
@en
Nanomicellar formulations for ...... ies and underlying principles.
@nl
P2860
P356
P1433
P1476
Nanomicellar formulations for ...... ies and underlying principles.
@en
P2093
Ruchit Trivedi
Uday B Kompella
P2860
P304
P356
10.2217/NNM.10.10
P577
2010-04-01T00:00:00Z